Payment overview · 2025
General Payments
We did not find matching Open Payments records for this doctor in the selected program year.
Healthcare provider profile · identity verified
Internal Medicine · MONROEVILLE, PA · NPI 1023083284
Verified facts
We did not find matching Open Payments records for this doctor in 2025.
These records do not establish that a payment influenced prescribing or medical care.
Payment overview · 2025
We did not find matching Open Payments records for this doctor in the selected program year.
Separate record types
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Analysis 1 · Payment-linked products
No payment-linked product analysis is available because no matching General Payment records were found for the selected year.
There is no explicit payment-product set available for a Part D comparison.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
There is no payer-company set available for this comparison.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Rosuvastatin Calcium | Rosuvastatin Calcium | 533 | 157 |
| Levothyroxine Sodium | Levothyroxine Sodium | 388 | 100 |
| Atorvastatin Calcium | Atorvastatin Calcium | 292 | 81 |
| Amlodipine Besylate | Amlodipine Besylate | 239 | 74 |
| Omeprazole | Omeprazole | 236 | 75 |
| Losartan Potassium | Losartan Potassium | 214 | 60 |
| Lisinopril | Lisinopril | 192 | 61 |
| Gabapentin | Gabapentin | 183 | 51 |
| Pantoprazole Sodium | Pantoprazole Sodium | 148 | 48 |
| Metformin Hcl Er | Metformin Hcl | 146 | 45 |
| Metoprolol Succinate | Metoprolol Succinate | 144 | 39 |
| Carvedilol | Carvedilol | 131 | 35 |
| Duloxetine Hcl | Duloxetine Hcl | 120 | 32 |
| Clonazepam | Clonazepam | 115 | 31 |
| Jardiance | Empagliflozin | 111 | 27 |
| Famotidine | Famotidine | 109 | 42 |
| Trazodone Hcl | Trazodone Hcl | 108 | 34 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 104 | 19 |
| Hydrochlorothiazide | Hydrochlorothiazide | 101 | 30 |
| Escitalopram Oxalate | Escitalopram Oxalate | 97 | 29 |
| Eliquis | Apixaban | 95 | 25 |
| Montelukast Sodium | Montelukast Sodium | 93 | 24 |
| Synthroid | Levothyroxine Sodium | 92 | 17 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 90 | 35 |
| Metoprolol Tartrate | Metoprolol Tartrate | 90 | 25 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 89 | 23 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 89 | 23 |
| Simvastatin | Simvastatin | 80 | 25 |
| Sertraline Hcl | Sertraline Hcl | 75 | 22 |
| Ozempic | Semaglutide | 71 | 11 |
| Metformin Hcl | Metformin Hcl | 69 | 20 |
| Pravastatin Sodium | Pravastatin Sodium | 68 | 20 |
| Celecoxib | Celecoxib | 67 | 20 |
| Tramadol Hcl | Tramadol Hcl | 62 | 22 |
| Lorazepam | Lorazepam | 61 | 11 |
| Fluticasone Propionate | Fluticasone Propionate | 59 | 22 |
| Glimepiride | Glimepiride | 59 | 16 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 58 | 17 |
| Citalopram Hbr | Citalopram Hydrobromide | 54 | 17 |
| Potassium Chloride | Potassium Chloride | 48 | 16 |
| Meloxicam | Meloxicam | 47 | 16 |
| Methylprednisolone | Methylprednisolone | 45 | 41 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 45 | 13 |
| Xarelto | Rivaroxaban | 45 | 11 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 43 | 13 |
| Ibuprofen | Ibuprofen | 41 | 12 |
| Allopurinol | Allopurinol | 38 | suppressed |
| Alprazolam | Alprazolam | 37 | suppressed |
| Januvia | Sitagliptin Phosphate | 34 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 34 | suppressed |
| Tamsulosin Hcl | Tamsulosin Hcl | 34 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 33 | suppressed |
| Clopidogrel | Clopidogrel Bisulfate | 33 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 32 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 32 | suppressed |
| Atenolol | Atenolol | 30 | suppressed |
| Bumetanide | Bumetanide | 28 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 28 | 12 |
| Furosemide | Furosemide | 28 | 11 |
| Methenamine Hippurate | Methenamine Hippurate | 28 | suppressed |
| Mirtazapine | Mirtazapine | 28 | suppressed |
| Bupropion Xl | Bupropion Hcl | 27 | suppressed |
| Chlorthalidone | Chlorthalidone | 27 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 27 | 23 |
| Zolpidem Tartrate | Zolpidem Tartrate | 27 | suppressed |
| Myrbetriq | Mirabegron | 26 | suppressed |
| Topiramate | Topiramate | 26 | suppressed |
| Trulicity | Dulaglutide | 26 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 25 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 25 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 25 | 15 |
| Valsartan | Valsartan | 25 | suppressed |
| Finasteride | Finasteride | 24 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 24 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 24 | 12 |
| Propranolol Hcl Er | Propranolol Hcl | 24 | suppressed |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 23 | 17 |
| Spironolactone | Spironolactone | 23 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 22 | suppressed |
| Pregabalin | Pregabalin | 22 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 21 | suppressed |
| Estradiol | Estradiol | 21 | 12 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 21 | suppressed |
| Azithromycin | Azithromycin | 20 | 19 |
| Eszopiclone | Eszopiclone | 20 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 20 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 20 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 20 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 19 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 18 | 15 |
| Mounjaro | Tirzepatide | 18 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 18 | 14 |
| Amoxicillin | Amoxicillin | 17 | 15 |
| Doxepin Hcl | Doxepin Hcl | 17 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 17 | suppressed |
| Armour Thyroid | Thyroid,pork | 16 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 16 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 16 | suppressed |
| Cephalexin | Cephalexin | 15 | suppressed |
| Creon | Lipase/Protease/Amylase | 15 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 15 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 15 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 15 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 15 | suppressed |
| Telmisartan-Hydrochlorothiazid | Telmisartan/Hydrochlorothiazid | 15 | suppressed |
| Diazepam | Diazepam | 14 | suppressed |
| Ezetimibe | Ezetimibe | 14 | suppressed |
| Ibu | Ibuprofen | 14 | suppressed |
| Olanzapine | Olanzapine | 14 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 14 | 14 |
| Prednisone | Prednisone | 14 | 13 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 13 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 13 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 13 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 13 | suppressed |
| Mometasone Furoate | Mometasone Furoate | 13 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 13 | suppressed |
| Sucralfate | Sucralfate | 13 | suppressed |
| Baclofen | Baclofen | 12 | suppressed |
| Cefuroxime | Cefuroxime Axetil | 12 | 12 |
| Clonidine | Clonidine | 12 | suppressed |
| Glipizide | Glipizide | 12 | suppressed |
| Glipizide Er | Glipizide | 12 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 12 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 12 | suppressed |
| Sildenafil Citrate | Sildenafil Citrate | 12 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 12 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 11 | 11 |
| Clorazepate Dipotassium | Clorazepate Dipotassium | 11 | suppressed |
| Fluconazole | Fluconazole | 11 | suppressed |
| Hydrocortisone | Hydrocortisone | 11 | suppressed |
| Irbesartan | Irbesartan | 11 | suppressed |
| Rizatriptan | Rizatriptan Benzoate | 11 | suppressed |
| Trospium Chloride | Trospium Chloride | 11 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 11 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 11 | suppressed |
Timeline
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | — | — | — | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error